Philippe Camus, M.D.

Dijon, France

Both apps are now back!

Back to drug

The Drug-Induced Respiratory Disease Website and App

Frequency - Incidence

Incidence of respiratory adverse event(s) due to the specific drug as assessed by number of reported/published cases in the literature. Red digits in stars indicate: 0 = Very rare, questionable signal · 1 = < 10 cases · 2 = 10-50 cases · 3 = 50–100 cases · 4 = 100-200 cases · 5 = >200 cases

Evidence level/grade

Evidence level for respiratory adverse event(s) due to the specific drug as estimated using Hill’s (1965), Naranjo’s (1981), and Bégaud’s (1985) criteria applied to published cases. Blue digits in stars indicate: 0 = Questionable · 1 = Low · 2 = Moderate · 3 = Robust · 4 = Definite · 5 = Unquestionable, pathognomonic

XLIX.f

Anaphylaxis-Anaphylactoid reaction (can be fatal)

Publications

Touraine F, Sainte Laudy J, Boumediene A, Ndikumwenayo F, Decroisette C, Melloni B, Vergnenegre A, Bonnaud F

[Investigation of allergic reactions to platinum salts].

Revue des maladies respiratoires 2006 Nov;23;458-62 — 2006 Nov — 458-62

Moreno-Ancillo A, Domínguez-Noche C, Gil-Adrados AC, Cosmes PM, Duarte I, Mateos Y

Anaphylactoid reaction to carboplatin: successful "desensitization".

Allergologia et immunopathologia 2003 Nov-Dec;31;342-4 — 2003 Nov-Dec — 342-4

Chang SM, Fryberger S, Crouse V, Tilford D, Prados MD

Carboplatin hypersensitivity in children. A report of five patients with brain tumors.

Cancer 1995 Mar 01;75;1171-5 — 1995 Mar 01 — 1171-5